Zivo Bioscience (ZIVO) Stock Analysis: AI Score & Alternative Data
ZIVO alt-data: web traffic climbing, headcount lagging
Is Zivo Bioscience a buy right now? The alternative data says hold. This ZIVO stock analysis is built on the 25+ alternative data signals AltIndex tracks on Zivo Bioscience every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 52/100: a Hold. The stock trades at $4.24 with a $15M market cap.
The bullish side of the 90-day ledger: web traffic up 19.9% to 5K monthly visits. The drag: headcount (according to LinkedIn) down 12.5% to 7 employees. That tension is what keeps the score mid-range.
Every signal links to its own page with full history, the ZIVO technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ZIVO is just below.
Zivo Bioscience AI Stock Analysis
Zivo Bioscience is a biotech company that focuses on developing and commercializing nutritional and therapeutic natural products derived from proprietary algal cultures. The company targets applications in animal health with an emphasis on immunomodulation and anti-inflammatory properties.
Analysis generated October 4, 2026.
Recent Zivo Bioscience Stock Alerts
|
Zivo Bioscience | October 2 Price is up by 7.3% in the last 24h. |
|
Zivo Bioscience | October 1 Price is up by 6.1% in the last 24h. |
|
Zivo Bioscience | September 25 Price is down by -8.3% in the last 24h. |
|
Zivo Bioscience | September 23 Price is up by 7% in the last 24h. |
Zivo Bioscience Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 5K | 19.9% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 7 | 12.5% | |
| Employee Recommend | 0 | N/A | |
| Business Outlook | 0 | N/A | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 5 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 2K | 0.5% |
About Zivo Bioscience (ZIVO)
ZIVO Bioscience, Inc., a research and development company, is dedicated to licensing and selling natural bioactive ingredients derived from its proprietary algal cultures to manufacturers of medical food and dietary, human and animal supplements. The company is headquartered in Keego Harbor, Michigan.
| Price | $4.24 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $15M |
| Year Range | $1 – $17 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Zivo Bioscience News
View more →| No recent news for ZIVO. |
See Zivo Bioscience’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for ZIVO, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEZivo Bioscience Earnings & Financial Performance
View all earnings →Zivo Bioscience Insider Trading Activity
View all →| STROME MARK E filed to sell 572,942 shares at $0.0. Apr 17 '26 |
| YALDOO LAITH L filed to sell 583,615 shares at $0.0. Feb 27 '26 |
| STROME MARK E filed to sell 45,071 shares at $0.0. Feb 12 '26 |
| STROME MARK E filed to sell 472,942 shares at $0.0. Feb 12 '26 |
| YALDOO LAITH L filed to sell 582,072 shares at $0.0. Feb 10 '26 |
Zivo Bioscience Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Zivo Bioscience
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Karyopharm TherapeuticsKPTI |
$0.60 7.0% | $15M | 48 |
 |
Tvardi TherapeuticsTVRD |
$1.08 1.8% | $15M | 55 |
 |
AEON BiopharmaAEON |
$0.31 0.4% | $14M | 48 |
 |
Pasithea TherapeuticsKTTA |
$0.44 0.6% | $15M | 45 |
 |
Vyome HoldingsHIND |
$2.03 0.5% | $14M | 47 |
Explore Zivo Bioscience Data
Frequently Asked Questions: Zivo Bioscience (ZIVO)
Zivo Bioscience has an AltIndex AI Score of 52/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
52/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Zivo Bioscience (ZIVO) stock is $4.24 with a market cap of $15M.
As of today, Zivo Bioscience’s PE (Price to Earnings) ratio is —.
View the latest Zivo Bioscience insider transactions to see recent buying and selling activity by company executives and directors.
Check the Zivo Bioscience congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ZIVO stock price chart above shows Zivo Bioscience’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Zivo Bioscience technical analysis for RSI, moving averages, and more.
See the stocks similar to Zivo Bioscience section on this page for companies in the same industry ranked by market cap and AI Score.
